Product Reports Resources Pricing Login Book a demo
Adel Nada
Person profile

Adel Nada

Super founder
2
Companies founded
$178M
Total funding raised
4 schools
Education

Companies founded

Currently

Active roles, board seats and partnerships.

TROYA Therapeutics
Scientific Advisor · 2024 – present
Ngbio
Investment Committee Member · 2024 – present
Akribion Therapeutics
Chair of the Board · 2024 – present
Volnay Therapeutics
Venture Partner · 2024 – present
A*STAR
Project Mentor · 2024 – present
Alia Therapeutics
Director · 2023 – present
Hemosense
Director

Work history

Past roles by Dealroom records.

Casebia Therapeutics
CMO · 2018 – 2019
Intellia Therapeutics
President · VP · 2015 – 2018
Lisata Therapeutics
President · VP · 2014 – 2015
Caladrius Biosciences
VP · 2014 – 2015
Baxter International
Director · 2012 – 2014
Baxter India Pvt.
Director · 2012 – 2014
Caprotec Bioanalytics
Principal Investigator · 2007
Charles river labs
2007
Charles River Laboratories International
2007
Abbott
Director · 2007 – 2012
Rush University Medical Center
Assistant · 2000 – 2007

Education

Rush University
Msc · 2001 – 2003
University of California, San Francisco
until 2010
University of Basel
until 2011
Alexandria University
Medicine, Surgery · until 1994
← All people